Medical records for thalassemia care in China: build a usable history of diagnosis, transfusions, iron, and treatment

The most informative thalassemia record is often a sequence rather than the latest test. A receiving clinician needs to understand how the diagnosis was established, what blood support has been required, how iron measurements have changed, and which medicines were actually used. Keep original reports and prepare a short summary that directs the reader to them. The summary should make the evidence easier to find without replacing it. TIF 2025: Multidisciplinary Care and Reference CentresTIF 2025: Summary of Monitoring Recommendations

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Include the patient's name and date of birth, principal diagnosis, approximate age at symptom onset and diagnosis, regular transfusion status, and the reason for seeking care in China. If classification is uncertain, say that it is the previous diagnosis being reviewed. Do not turn an unresolved finding into a definitive subtype simply to make the document look complete. Origa et al.: Genetic Basis, Pathophysiology, and Diagnosis, TIF 2025
For each medicine, provide generic and brand names, strength, formulation, amount per dose, frequency, start date, changes, and the prescriber. Different formulations may have different administration requirements; shortening them all to a generic name and a milligram number can lose important information. Note interruptions due to adverse effects, access difficulties, or missed doses without concealing them. DailyMed: Deferasirox tablets for suspension, current prescribing information DailyMed: FERRIPROX deferiprone tablets, January 2026 prescribing information
If a new fever, hospitalization, transfusion, or medication change occurs after submission, put it on a separate dated update. Carry the key summary, serious allergy information, and blood-bank history in an accessible form, with the full collection available electronically. Write down the questions the patient most wants answered. The purpose of the preparation is to make the real clinical course understandable and leave more consultation time for decisions that matter.

Quick answer

Full guide

Make the first page explain the consultation

Include the patient's name and date of birth, principal diagnosis, approximate age at symptom onset and diagnosis, regular transfusion status, and the reason for seeking care in China. If classification is uncertain, say that it is the previous diagnosis being reviewed. Do not turn an unresolved finding into a definitive subtype simply to make the document look complete. Origa et al.: Genetic Basis, Pathophysiology, and Diagnosis, TIF 2025

Describe the two or three problems currently affecting the patient most. These might include increasing fatigue between transfusions, difficulty tolerating chelation, or a reproductive question. Make serious allergies, major transfusion reactions, splenectomy, and transplantation easy to locate. When prior clinicians disagree, retain their dated opinions instead of silently selecting one as the final answer.

Preserve the complete genetic laboratory report

Include all pages describing the method, coverage, variant names, interpretation, specimen, and laboratory. A common-variant panel, deletion analysis, and broader sequencing answer different questions. The meaning of a negative result depends on what was examined. If the available paper only says alpha-thalassemia positive, ask the original laboratory whether a more detailed report can be obtained. ARUP Consult: Thalassemias, updated April 2026 GeneReviews: Alpha-Thalassemia, current review

For beta-thalassemia, retain the exact findings and their interpretation, including relevant combinations with other hemoglobin variants. Label relatives' results with their relationship to the patient. A partner's or parent's report must not appear as the patient's own result. A variant of uncertain significance should remain uncertain in translation, and its clinical interpretation should stay with the qualified team. Langer: Beta-Thalassemia, GeneReviews, revision February 12, 2026

Do not retype complicated variant notation from memory. An accurate scan of the original alongside a translation is safer than an edited summary that changes punctuation or loses part of the name. Where a laboratory has issued an amended report, retain the latest version and make clear that it supersedes the earlier interpretation.

Put hemoglobin analysis in its treatment context

Bring complete electrophoresis, HPLC, or other hemoglobin-analysis results and available traces. Record whether transfusion preceded sampling and the date of the most recent transfusion, since donor red cells can affect the observed pattern. Newborn screening and early pretreatment findings may also help the clinician understand the original phenotype. Origa et al.: Genetic Basis, Pathophysiology, and Diagnosis, TIF 2025 NHLBI: Thalassemia diagnosis

Do not stop medically needed transfusions in an attempt to produce an uncontaminated sample. The clinician and laboratory can decide what further testing is appropriate under the current circumstances. The record preparer's task is to identify relevant conditions around the sample, not to invent a treatment interruption for diagnostic convenience.

Build a transfusion table with actual dates and quantities

For each available episode, list the date, red-cell component, volume or reported units, pretransfusion hemoglobin, and any special clinical circumstances. If a post-transfusion value is included, record when it was measured. Units may represent different volumes between blood services, so preserve the original description and any documented milliliter amount rather than converting everything with an assumed factor. Shah, Wood and Maggio: Blood Transfusion, TIF 2025

Ask the receiving team how much historical detail is useful for the particular question. The record should show the recent usual pattern and any change. Mark an additional transfusion given during infection separately from routine support. For a child, include contemporaneous body weight where available, allowing clinicians to interpret the quantity without asking the family to calculate a new dose. 中国儿童输血依赖型地中海贫血输血管理指南，2025，中国当代儿科杂志

If the available history has gaps, identify them openly. A careful partial record is more useful than a polished table containing estimates presented as measured facts. The local clinic or blood service may be able to supply missing dates and component information directly.

Give the blood-bank history its own section

Collect ABO and Rh information, extended phenotype or genotype results already performed, antibody identifications, compatibility difficulties, and reaction investigations. List every historically identified antibody with its date, including antibodies no longer detected on recent testing. If the patient remembers an antibody but lacks the report, mark it as requiring retrieval from the original blood bank. Shah, Wood and Maggio: Blood Transfusion, TIF 2025

For a serious reaction, preserve the investigation's conclusion and indicate whether symptoms occurred during transfusion or days later. Keep relevant laboratory results with the episode. A patient's recollection should be identified as a recollection, not rewritten as a confirmed mechanism. The Chinese team can then determine what requires direct verification with the originating institution.

Place this section where it is easy to find rather than burying it among ordinary blood counts. A current negative screen should not cause older antibody reports to be removed. Good organization helps the receiving service recognize a special requirement before an urgently needed transfusion is due.

Link iron measurements to methods and source images

Record serial ferritin values with dates and units, noting concurrent infection or liver problems when known. Liver-iron MRI reports should retain the quantitative measurement, unit, method, and institution. Cardiac T2* belongs in a separate series. A photograph showing only a number labeled iron is insufficient for reliable comparison. Porter, Wood and Coates: Iron Overload and Chelation, TIF 2025 中国地中海贫血祛铁治疗指南，2025，中国当代儿科杂志

Ask the radiology service how to obtain readable original image data and check the receiving hospital's accepted format. State any expiry date for an online image link and keep an accessible backup. Echocardiography, ECG, and ambulatory rhythm-monitoring reports can be added chronologically, but they should not be described as interchangeable with cardiac iron measurements. TIF 2025: Cardiovascular Disease in TDT

If two reports use different units or methods, preserve both and flag the difference. Let the specialist decide whether the trend can be compared or whether reassessment is necessary. A document organizer should not recalculate a liver-iron value using an unverified internet conversion.

Record how medicines were actually taken

For each medicine, provide generic and brand names, strength, formulation, amount per dose, frequency, start date, changes, and the prescriber. Different formulations may have different administration requirements; shortening them all to a generic name and a milligram number can lose important information. Note interruptions due to adverse effects, access difficulties, or missed doses without concealing them. DailyMed: Deferasirox tablets for suspension, current prescribing information DailyMed: FERRIPROX deferiprone tablets, January 2026 prescribing information

For infused deferoxamine, include information about the device and actual use. For injected therapies, retain administration dates and observed reactions. Put supplements, herbal products, vitamins, contraception, and nonprescription medicines on the same list. Some newer oral treatments have liver-safety monitoring and interaction requirements that cannot be assessed from the description thalassemia medication. DailyMed: DESFERAL deferoxamine prescribing information DailyMed: AQVESME mitapivat prescribing information

Attach relevant monitoring results to a dated change where possible. This allows the clinician to distinguish lack of effect from insufficient exposure, a toxicity-related interruption, or a measurement taken before the adjustment could be evaluated. The patient does not need to judge the correct response; accurate timing is the useful contribution.

Group complications by the organ involved

Create small sections for cardiac, liver, endocrine, and bone problems, each containing the diagnosis, decisive investigations, current treatment, and unresolved question. Hepatitis-related results need dates and treatment history. A negative result obtained years ago should not be presented as a statement of current status. Include planned follow-up when a clinician has already specified it. TIF 2025: Liver Disease in TDT Aydinok et al.: Other Complications, TIF 2025

For children, growth charts, pubertal assessment, and bone-age information may be more informative than a single height. Adults can include metabolic, thyroid, bone-density, and other investigations already performed. Do not commission every possible test merely to fill the record. The receiving clinician can determine additional needs from age, clinical findings, and risk. Casale et al.: Growth Abnormalities, Endocrine, and Bone Disease, TIF 2025

Separate a reported symptom from a diagnosed complication. For example, the patient's description of palpitations should remain available even if the cause has not been established. Keeping this distinction avoids turning a preliminary concern into a false diagnosis in the translated summary.

Include what happened after splenectomy or another operation

Alongside the operation name and date, retain the discharge summary, pathology when relevant, complications, and infection-prevention instructions. Vaccination records should identify vaccine names, dates, and doses rather than simply saying complete. For previous thrombosis, bring the diagnostic imaging and the dated anticoagulation history, including the documented reason for stopping if available. Amid and Merkeley: Splenomegaly and Splenectomy, TIF alpha guideline 2023 TIF 2023: Hypercoagulability and Thrombotic Disease in NTDT

Recent postoperative restrictions, wound-care instructions, and scheduled reviews may influence travel or a subsequent treatment plan. Unknown details should stay marked as unknown. Do not add preventive medicines to the list merely because they are commonly discussed online for someone who has had the same operation.

Request a dedicated transplant or gene-therapy summary

After allogeneic transplantation, useful details include donor and matching information, conditioning, cell source, infusion date, engraftment, chimerism results, infections, and GVHD. Date immunosuppressant changes and drug-level measurements. Mixed chimerism requires clinical interpretation and should not be translated automatically as transplant failure. Pinto et al.: Haematopoietic Cell Transplantation, TIF 2025

After gene addition or editing, preserve the exact product or study, conditioning and infusion dates, responsible contacts, and long-term monitoring instructions. Requirements differ between products. Patient copies of consent and follow-up documents may clarify responsibilities for the receiving clinician; discuss the appropriate recipient and secure route before sharing them. Locatelli and Algeri: Gene Manipulation, TIF 2025 中国药物临床试验质量管理规范，2026年修订，辽宁省药监局公布全文

These records should distinguish routine clinical monitoring from research assessments. If some tests are scheduled through a sponsor or study site, name that arrangement rather than assuming the local hospital will reproduce it automatically. A dated plan makes it easier for both teams to discuss which responsibilities can be transferred.

Keep reproductive records attached to the correct person

Use separate folders for partners, retaining names, relationships, and original laboratory identifiers. A joint summary can then state the counseling question. During pregnancy, include the basis for gestational age, ultrasound findings, and prenatal diagnostic results with dates. Prior counseling notes may show which risks and options were already discussed. Lianoglou: Genetic Counselling for Families at Risk for Alpha-Thalassaemia, TIF 2023 TIF 2025: Fertility and Pregnancy

Fetal records need the relevant maternal context as well. An isolated ultrasound image cannot provide the full assessment. Mark a pending test as pending and identify the laboratory expected to issue it. Time-sensitive results should be brought directly to the obstetric team's attention rather than hidden at the end of a large collection. TIF 2023: Prenatal Management of Haemoglobin Barts Hydrops Foetalis

Translate and label files so they remain verifiable

Pair each translation with the original. Check numerical values, units, reference ranges, dates, and negatives carefully. Leave an uncertain abbreviation visible and flag it for clarification. Not detected should not become all disease excluded. Use dates and meaningful content names for files, add a short index, and put the most relevant records first.

Confirm the hospital's authorized submission channel and the recipient. An initial clinical inquiry should contain the information needed for assessment; identity and administrative documents can be handled through the actual institutional process. Public forums are unsuitable for full identity documents or unredacted family reports. Record what has been received and what still needs to be supplied so that follow-up requests can be specific.

Do not remove an original merely because the translation appears easier to read. Different laboratories may express the same concept differently, and the clinician may need the original wording to resolve a discrepancy. If a translation is uncertain, state that plainly rather than presenting a guess as a laboratory conclusion.

Add an update sheet for the consultation day

If a new fever, hospitalization, transfusion, or medication change occurs after submission, put it on a separate dated update. Carry the key summary, serious allergy information, and blood-bank history in an accessible form, with the full collection available electronically. Write down the questions the patient most wants answered. The purpose of the preparation is to make the real clinical course understandable and leave more consultation time for decisions that matter.